Long-Acting Injectable PrEP Feasible, Acceptable To Both Men And Women, Study Suggests

Healio (7/19, Feller) reported, “Long-acting injectable PrEP is feasible and acceptable to both men and women, according to a study.” According to Healio, “as long-acting cabotegravir (CAB-LA) has recently been rolled out in Africa, researchers reported that not only did many people prefer it to taking a daily pill, but also that it could be a safer option.” The findings were presented at the AIDS 2024 meeting.